KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Gross Profit Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.90%
Dec 31, 2025 30.04%
Sep 30, 2025 0.16%
Jun 30, 2025 14.04%
Mar 31, 2025 2.19%
Dec 31, 2024 5.24%
Sep 30, 2024 13.75%
Jun 30, 2024 2.46%
Mar 31, 2024 6.80%
Dec 31, 2023 -3.23%
Sep 30, 2023 -0.34%
Jun 30, 2023 -1.78%
Mar 31, 2023 -3.86%
Dec 31, 2022 -17.42%
Sep 30, 2022 -0.36%
Jun 30, 2022 -1.80%
Mar 31, 2022 2.16%
Dec 31, 2021 15.04%
Sep 30, 2021 2.57%
Jun 30, 2021 2.02%
Mar 31, 2021 0.88%
Dec 31, 2020 -10.90%
Sep 30, 2020 7.46%
Jun 30, 2020 2.67%
Mar 31, 2020 3.89%
Dec 31, 2019 3.01%
Sep 30, 2019 3.21%
Jun 30, 2019 3.36%
Mar 31, 2019 4.02%
Dec 31, 2018 -2.85%
Sep 30, 2018 6.09%
Jun 30, 2018 8.24%
Mar 31, 2018 5.25%
Dec 31, 2017 32.97%
Sep 30, 2017 8.52%
Jun 30, 2017 10.06%
Mar 31, 2017 5.93%
Dec 31, 2016 13.73%
Sep 30, 2016 8.23%
Jun 30, 2016 6.10%
Mar 31, 2016 6.69%
Dec 31, 2015 9.78%
Sep 30, 2015 7.16%
Jun 30, 2015 2.74%
Mar 31, 2015 1.72%
Dec 31, 2014 -5.26%
Sep 30, 2014 3.45%
Jun 30, 2014 1.53%
Mar 31, 2014 9.46%